Literature DB >> 18754437

[Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].

Yu-mei Liang1, Xiang-hong Li, Wei Chen.   

Abstract

OBJECTIVE: To investigate the roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors (GISTs).
METHODS: The clinical data of 102 patients of GIST, 60 with gastric stromal tumor and 42 with small intestinal stromal tumor were collected. The relations of disease free survival rate and disease specific overall survival rate to Ki-67 index and risk assessment were analyzed.
RESULTS: Risk assessment showed that 2 cases were at very low risk, 14 at low risk, 16 at intermediate risk, and 28 at high risk. As classified by the Ki-67 index system, 13 cases were in the group of Ki-67 index > or =5%, and the other 47 cases were in the group of Ki-67 index <5%. The patients with high risk or Ki-67 index > or =5% had significantly lower disease-free survival rates (Pki-67 = 0.001, P risk assessment = 0.044) and disease specific overall survival rates (Pki-67 = 0.001, P risk assessment = 0.007). The high-risk patients had significantly lower survival rate than the patients of other grades (P disease-free = 0.044, P over all = 0.012). In the 42 patients with small intestinal stromal tumor 9 were at low risk, 11 at intermediate risk, and 22 at high risk;and there were 12 cases with Ki-67 index > or =5% and 30 cases with Ki-67 index <5%. Risk assessment had no relationship with disease specific overall survival rate. The overall survival rate of the intestinal stromal tumor patients with the Ki-67 index > or =5% was significantly lower than that of those with the K-67 index <5% (P = 0.039), however, Ki-67 index was not related to disease free survival rate. Four of the gastric stromal tumor patients at low and intermediate risk and with Ki-67 index > or =5% suffered recurrence or metastasis; and 2 similar cases were found in the small intestinal stromal tumor cases.
CONCLUSION: Risk assessment and Ki-67 index are good prognostic indicators for gastric stromal tumors. In small intestinal stromal tumors, risk assessment is only related to disease free survival rate, and Ki-67 index is related to disease specific overall survival rate. In the GIST patients at low and intermediate risk, Ki-67 can be a good complimentary indicator to predict the recurrence or metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754437

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  3 in total

1.  Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population.

Authors:  Jiehua Li; Haitian Zhang; Zhibai Chen; Ka Su
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

Review 2.  Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors: A systematic review and meta-analysis.

Authors:  Yu Zhou; Wenqing Hu; Ping Chen; Masanobu Abe; Lei Shi; Si-Yuan Tan; Yong Li; Liang Zong
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

3.  Relationship between Ki-67 and CD44 expression and microvascular formation in gastric stromal tumor tissues.

Authors:  Bing Ma; Xiao-Tian Huang; Gui-Jun Zou; Wen-Yu Hou; Xiao-Hui Du
Journal:  World J Clin Cases       Date:  2022-01-14       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.